Тиреотропинома: трудности дифференциальной диагностики (Клинический случай)

Тиреотропинома – одна из редких причин развития тиреотоксикоза. Ошибки в дифференциальной диагностике с другими причинами тиреотоксикоза ведут к необоснованному проведению хирургического вмешательства на щитовидной железе или радиойодтерапии. В статье представлены современные данные об особенностях патогенеза, диагностики, дифференциальной диагностики и лечения ТТГ-секретирующих аденом; описан клинический случай тиреотропиномы у молодой женщины.

тиреотропинома, тиреотоксикоз, аденома гипофиза

1. Кадашев Б.А., Астафьева Л.И. Аденомы гипофиза. Тверь, 2007. С. 152–155.

2. Ando S., Sarlis N.J., Krishan J. et al. Abberant alternative splicing of thy-roid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance // Mol. Endocr. 2001. V. 15. P. 1529.

3. Ando S., Sarlis N.J., Oldfield E.H., Yen P.M. Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor // J. Clin. Endocr. Met. 2001. V. 86. P. 5572.

4. Baur A., Buchfelder M., Kohrle J. Expression of 5'-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas // Eur. J. Endocr. 2002. V. 147. P. 263.

5. Beck-Peccos P., Brueker-Davis F., Persani L. et al. Thyrotropin-secreting pituitary tumors // Endocr. Rev. 1996. V. 17. P. 610.

6. Beck-Peccoz P., Persani L. TSH-induced hyperthyroidism caused by a pituitary tumor. Nat.Clin. Pract. Endocrinol. Metab. 2006. V.2 (9). P. 524–528.

7. Beck-Peccos P., Roncoroni R., Mariotti S. et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (1ST): evidence against selective pituitary thyroid hormone resistance in non-neoplastic 1ST // J. Clin. Endocr. Met. 1990. V. 71. P. 19.

8. Chanson P., Weintraub B.D., Harris A.G. Octreotide therapy for thyroid stimulating hormone-secreting pituitary adenomas: A follow up of 52 patients // Ann. Intern. Med. 1993. V. 119. P. 236.

9. Chatterjee V.K.K., Clifton-Bright R.J., Gurnell M. Thyroid hormone resistance. In: Jameson JL, ed: Contemporary Endocrinology: Hormone Resistance Syndromes. Totowa. Humana Press, 1999. Р. 145–153

10. Dong Q., Brucker-Davis F., Weintraub B.D. et al. Screening of candidate oncogenes in human thyrotropin tumors: absence of activating mutations of the Gall, Gas, or thyrotropin-releasing hormone receptor genes // J. Clin. Endocr. Met. 1996. V. 81. P. 1134.

11. Gesundheit N., Petrick P., Nissim M. et al. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity // An. Intern. Med. 1989. V. 111. P. 827.

12. Ghannam N.N., Hammami M.M., Muttair Z. et al. Primary hypothyroidism – associated TSH-secreting pituitary adenoma/hyperplasia presenting as a bleed-ing nasal mass and extremely elevated TSH level // J. Endocr. Invest. 1999. V. 22. P. 419.

13. Hamilton C., Adams L.C., Maloof F. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma // N. Engl. J. Med. 1970. V. 283. P. 1077.

14. Jailer J.W., Holub D.A. Remission of Graves' disease following radiother-apy of a pituitary neoplasm // Am. J. Med. 1960. V. 28. P. 497.

15. Losa M., Magnani P., Mortini P. et al. Indium-Ill pentetreotide single-photon emission tomography in patients with TSH-secreting pituitary adenomas: correlation with the effect of a single administration of octreotide on cerum TSH levels // Eur. J. Nucl. Med. 1997. V. 24. P. 728.

16. Mindermann Т., Wilson C.B. Thyrotropin-producing pituitary adenomas // J. Neurosurg. 1993. V. 79. P. 521.

17. Mixson A.J., friedman T.C., David A.K. et al. Thyrotropin-secreting pitui-tary carcinoma // J. Clin. Endocr. Met. 1993. V. 76. P. 529.

18. Nabarro J.D.N. Acromegaly // Clin. Endocr. 1987. V. 26. P. 481.

19. Persani L., Preziati D., Matthews C.H. et al. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagno-sis of the syndromes of inappropriate secretion of TSH // Clin. Endocr. 1997. V. 47. P. 207.

20. Sanno N., Teramoto A., Matsuno A. et al. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1 // Mod. Pathol. 1994. V. 7. P. 893.

21. Smallridge R.C. Metabolic, physiologic and clinical indexes of thyroid function. Werner and Ingbar's The Thyroid. 7th ed. Philadelphia: Lippincott, 1996. P. 397.

22. Tannahill L.A., Visser T.J., McCabe C.J. et al. Disregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumors // Clin. Endocr. 2002. V. 56. P. 735.

23. Terzolo M., Orlandi F., Basseti M. et al. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin // J. Clin. Endocr. Met. 1991. V. 72. P. 415.

24. Yamakita N., Ikeda Т., Murai T. et al. Thyrotropin-producing pituitary adenoma discovered as a pituitary incidentaloma. Intern Med. 1995. V. 34 (11). P. 1055–1060.